PEP-Therapy
Latest round
- Series A
Last raised
- May 2021
Total raised
- $4M
Investors
- 5
About PEP-Therapy
Founded in 2014 and headquartered in Paris, France, PEP-Therapy focuses on developing innovative cancer therapies.PEP-Therapy specializes in the development of innovative peptide-based therapies aimed at targeting various forms of cancer, particularly pancreatic cancer and ovarian adenocarcinoma. Their lead product, PEP-010, has received FDA Orphan Drug Designation for the treatment of pancreatic cancer. PEP-010 functions by inducing apoptosis in cancer cells, which can be monitored through pharmacodynamic biomarkers, providing a measurable response to treatment. The company has also demonstrated PEP-010's efficacy as a monotherapy and in combination with paclitaxel for resistant forms of ovarian adenocarcinoma.4 mn, with a reported EBITDA of EUR -990,890 in 2020. The company aims to expand its product offerings and may look to enter new markets as it progresses with its clinical trials and development initiatives.
Who invested in PEP-Therapy
5 investors across 2 rounds
See all investors in PEP-Therapy
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about PEP-Therapy
Who invested in PEP-Therapy?
PEP-Therapy has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has PEP-Therapy raised?
PEP-Therapy has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did PEP-Therapy last raise money?
PEP-Therapy's most recent round on record is a Series A, in May 2021.
What does PEP-Therapy do?
Founded in 2014 and headquartered in Paris, France, PEP-Therapy focuses on developing innovative cancer therapies.
Where is PEP-Therapy headquartered?
PEP-Therapy is headquartered in Paris, France.
Which VCs invest in companies like PEP-Therapy?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at PEP-Therapy's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like PEP-Therapy? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.